Search at Vanderbilt-Ingram Cancer Center

1120 results found

A Global Study of Volrustomig (MEDI5752) for Participants With Unresected Locally Advanced Head and Neck Squamous Cell Carcinoma Following Definitive Concurrent Chemoradiotherapy

Relevance: 1

A Trial to Learn if Odronextamab is Safe and Well-tolerated and How Well it Works Compared to Rituximab Combined With Different Types of Chemotherapy for Participants With Follicular Lymphoma

Relevance: 1

Heated Intraperitoneal Chemotherapy Followed by Niraparib for Ovarian, Primary Peritoneal and Fallopian Tube Cancer

Relevance: 1

Adding Nivolumab to Usual Treatment for People with Advanced Stomach or Esophageal Cancer, The PARAMMUNE Trial

Relevance: 1

Comparing the Combination of Selinexor-Daratumumab-Velcade-Dexamethasone (Dara-SVD) with the Usual Treatment (Dara-RVD) for High-Risk Newly Diagnosed Multiple Myeloma

Relevance: 1

Study of Lurbinectedin in Combination With Doxorubicin Versus Doxorubicin Alone as First-line Treatment in Participants With Metastatic Leiomyosarcoma

Relevance: 1

Testing the Use of Neratinib or the Combination of Neratinib and Palbociclib Targeted Treatment for HER2+ Solid Tumors (A ComboMATCH Treatment Trial)

Relevance: 1

A Study Using a New Drug, Nivolumab, in Combination with Chemotherapy Drugs to Treat a Type of Cancer Called Nasopharyngeal Carcinoma (NPC)

Relevance: 1

Durvalumab with Gemcitabine and Cisplatin for the Treatment of High Risk Resectable Liver Cancer Before Surgery

Relevance: 1

P-CD19CD20-ALLO1 Allogeneic CAR-T Cells in the Treatment of Subjects With B Cell Malignancies

Relevance: 1